Oliver Lagore Vanvalin Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12
| Closed | -$5.02K | – | 823 |
|
|
2024
Q1 | $5.02K | Hold |
12
| – | – | ﹤0.01% | 503 |
|
|
2023
Q4 | $4.88K | Hold |
12
| – | – | ﹤0.01% | 521 |
|
|
2023
Q3 | $4.17K | Hold |
12
| – | – | ﹤0.01% | 577 |
|
|
2023
Q2 | $4.22K | Hold |
12
| – | – | ﹤0.01% | 587 |
|
|
2023
Q1 | $3.78K | Hold |
12
| – | – | ﹤0.01% | 520 |
|
|
2022
Q4 | $3.47K | Hold |
12
| – | – | ﹤0.01% | 507 |
|
|
2022
Q3 | $3K | Hold |
12
| – | – | ﹤0.01% | 509 |
|
|
2022
Q2 | $3K | Hold |
12
| – | – | ﹤0.01% | 480 |
|
|
2022
Q1 | $3K | Buy |
+12
| New | +$3K | ﹤0.01% | 483 |
|